Jill M. Quigley - 15 Nov 2023 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Sr. Advisor & Strategy Officer, Director
Signature
/s/ Bryan Yoon as Attorney-in-Fact for Jill M. Quigley
Issuer symbol
TERN
Transactions as of
15 Nov 2023
Net transactions value
$0
Form type
4
Filing time
17 Nov 2023, 18:10:49 UTC
Previous filing
20 Jun 2023
Next filing
25 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Award $0 +15,000 $0.000000 15,000 15 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). 100% of the RSUs will vest on August 1, 2024 (the "Vesting Date"), subject to the Reporting Person's continued service to the Issuer through the Vesting Date.